Cyclotek is a radiopharmaceutical contract development and manufacturing organisation (CDMO). Cyclotek offers a range of Good Manufacturing Practice compliant (cGMP) diagnostic and therapeutic radiopharmaceuticals for use clinical trials and routine clinical management. Diagnostic radiopharmaceuticals provide patient-specific, accurate assessment of disease state. Paired with therapeutic radiopharmaceuticals, radiopharmaceutical products offer a comprehensive, non-invasive disease management option.

Cyclotek's mission is to make radiopharmaceuticals accessible in the Asia Pacific.

We offer a full CDMO service that spans the entire radiopharmaceutical value chain. We partner with local and international pharma/biotech companies to develop, manufacture and supply the highest quality, cGMP radiopharmaceutical products into the APAC market. Our CDMO services can be tailored to meet the development needs of our partners, enabling cost effective, phase appropriate clinical translation.

Why work with us

Through industry and academic partnerships, Cyclotek offers state-of-the-art radiopharmaceutical research and development (R&D) services. Our R&D laboratories are fully equipped to support the pre-clinical evaluation of novel radiopharmaceutical products.

Cyclotek’s CDMO team specialises in the development and validation of automated radiochemical synthesis and quality control processes. With extensive experience in the disciplines of radiochemistry, quality control, quality assurance engineering and regulatory, we have the expertise to support the translation and phase appropriate validation of your product. Our manufacturing facilities contain cyclotrons, multiple shielded manufacturing cells, a suite of automated synthesis platforms and dispensing cells. With an unmatched logistics network, we reliably manufacture and supply across all stages of the product lifecycle, from pre-clinical to scaled, commercial supply.